{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:38:21Z","timestamp":1778657901666,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaci.2018.02.053","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T02:53:27Z","timestamp":1524797607000},"page":"235-245.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Neelam","family":"Panchal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begona","family":"Diez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujal","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Bobby","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.02.053_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib2","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.165.6.2932","article-title":"Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome","volume":"165","author":"Tangye","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.02.053_bib3","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood-2004-08-3269","article-title":"SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells","volume":"105","author":"Dupre","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.02.053_bib4","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3","article-title":"Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity","volume":"30","author":"Nakajima","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.02.053_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.20042432","article-title":"Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product","volume":"201","author":"Pasquier","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib6","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4049\/jimmunol.181.4.2311","article-title":"Differential requirement for the SAP-Fyn interaction during NK T cell development and function","volume":"181","author":"Nunez-Cruz","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.02.053_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1073\/pnas.0710698105","article-title":"SAP expression in\u00a0T\u00a0cells, not in B cells, is required for humoral immunity","volume":"105","author":"Veillette","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.02.053_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature01318","article-title":"SAP is required for generating long-term humoral immunity","volume":"421","author":"Crotty","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.02.053_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature07345","article-title":"SAP-controlled T-B cell interactions underlie germinal centre formation","volume":"455","author":"Qi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.02.053_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.02.053_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","article-title":"Treating immunodeficiency through HSC gene therapy","volume":"22","author":"Booth","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood-2012-07-445858","article-title":"SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease","volume":"121","author":"Rivat","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.02.053_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.02.053_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T\u00a0lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.02.053_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1006\/mthe.2002.0611","article-title":"A\u00a0phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy","volume":"5","author":"Deeks","year":"2002","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2018.02.053_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V96.3.785.015k10_785_793","article-title":"Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta\u00a0gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects","volume":"96","author":"Mitsuyasu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.02.053_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical\u00a0haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaci.2018.02.053_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s002510000215","article-title":"Genomic organization and\u00a0characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease","volume":"51","author":"Wu","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaci.2018.02.053_bib19","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1073\/pnas.131193098","article-title":"Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/SAP","volume":"98","author":"Czar","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.jaci.2018.02.053_bib20","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood-2004-07-2731","article-title":"Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap","volume":"106","author":"Al-Alem","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.02.053_bib21","doi-asserted-by":"crossref","first-page":"12537","DOI":"10.1128\/JVI.78.22.12537-12547.2004","article-title":"Murine T cells potently restrict human immunodeficiency virus infection","volume":"78","author":"Baumann","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2018.02.053_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaci.2015.05.036","article-title":"Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies","volume":"136","author":"Ma","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.02.053_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","article-title":"Generation of T\u00a0follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages","volume":"29","author":"Nurieva","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.02.053_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","article-title":"A fundamental role for interleukin-21 in the generation of T follicular helper cells","volume":"29","author":"Vogelzang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.02.053_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.20141380","article-title":"BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms","volume":"212","author":"Hatzi","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20151467","article-title":"Unique and\u00a0shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets","volume":"213","author":"Ma","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib27","doi-asserted-by":"crossref","first-page":"e17739","DOI":"10.1371\/journal.pone.0017739","article-title":"IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation","volume":"6","author":"Eto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.02.053_bib28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.02.053_bib29","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2003-09-3359","article-title":"SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease","volume":"103","author":"Sharifi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.02.053_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2018.02.053_bib31","doi-asserted-by":"crossref","first-page":"317ra198","DOI":"10.1126\/scitranslmed.aac8265","article-title":"Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory","volume":"7","author":"Oliveira","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib32","doi-asserted-by":"crossref","first-page":"273ra13","DOI":"10.1126\/scitranslmed.3010314","article-title":"In\u00a0vivo tracking of T cells in humans unveils decade-long survival and activity\u00a0of genetically modified T memory stem cells","volume":"7","author":"Biasco","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2018.02.053_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918306195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918306195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:10:34Z","timestamp":1758791434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918306195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0091674918306195"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.02.053","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733133023.793572308","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}